SOX2 and osteosarcoma: For instance, research conducted by Zhiqiang Zhao and colleagues has demonstrated that DHM can inhibit the tumorigenesis of osteosarcoma by modulating the P38 (MAPK) and AMPKα/GSK3β/Sox2 signaling pathways (Zhao et al., 2014).